The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net earnings | 745 | 849 | 859 | 884 |
| Depreciation | 120 | 127 | 120 | 109 |
| Amortization of intangible assets | 180 | 189 | 189 | 187 |
| Asset impairments | 0 | 7 | 73 | 55 |
| Share-based compensation | 87 | 48 | 62 | 49 |
| Sale of inventory stepped up to fair value at acquisition | - | 173 | - | - |
| Sale of inventory stepped-up to fair value at acquisition | -164 | - | 90 | 74 |
| Deferred income tax (benefit) expense | -33 | 201 | 15 | 162 |
| Accounts receivable | -444 | 397 | -267 | -113 |
| Inventories | 127 | -76 | 147 | 133 |
| Accounts payable | -198 | 299 | 64 | 40 |
| Accrued expenses and other liabilities | -654 | 396 | 38 | 388 |
| Income taxes | 42 | 432 | 33 | -659 |
| Other, net | 25 | 97 | 94 | 149 |
| Net cash provided by operating activities | 581 | 2,143 | 1,540 | 1,111 |
| Acquisitions, net of cash acquired | 22 | 10 | 136 | 65 |
| Purchases of marketable securities | -16 | - | 5 | 16 |
| Proceeds from maturity of short-term investments | - | - | - | 0 |
| Proceeds/(purchases) of short-term investments | 0 | 0 | -750 | - |
| Proceeds from sales of marketable securities | -16 | - | 8 | 15 |
| Purchases of property, plant and equipment | 166 | 268 | 187 | 183 |
| Proceeds from settlement of net investment hedges | - | - | 0 | 0 |
| Proceeds from the sale of the spinal implants business | - | 0 | 0 | 165 |
| Other investing, net | -1 | 19 | 1 | 20 |
| Net cash used in investing activities | -185 | -305 | -321 | -104 |
| Proceeds (payments) on short-term borrowings, net | - | -1 | -1 | 2 |
| Proceeds from issuance of long-term debt | 0 | 0 | 0 | 0 |
| Payments on long-term debt | 1,000 | 750 | 0 | 650 |
| Payments of dividends | 337 | 321 | 322 | 321 |
| Cash paid for taxes from withheld shares | 139 | 17 | 17 | 14 |
| Other financing, net | -34 | -4 | 1 | -6 |
| Net cash provided by (used in) financing activities | -1,510 | -1,093 | -339 | -989 |
| Effect of exchange rate changes on cash and cash equivalents | -19 | 10 | 1 | 37 |
| Change in cash and cash equivalents | -1,133 | 755 | 881 | 55 |
| Cash and cash equivalents at beginning of period | 4,011 | 3,256 | 2,375 | 2,320 |
| Cash and cash equivalents at end of period | 2,878 | 4,011 | 3,256 | 2,375 |
STRYKER CORP (SYK)
STRYKER CORP (SYK)